The 2022 BU CTSI Impact Report

The 2022 BU CTSI Impact: Noteworthy Achievements, Accomplishments, & Success Stories
“We are delighted to present this report from the Boston University Clinical and Translational Science Institute (BU CTSI) for 2022. The BU CTSI has affected most aspects of translational research since it was first funded by the National Institutes of Health in 2008. The original, and continued, goal of our CTSI is to build a translational science infrastructure that supports standard research practices and funds novel ideas from BU and BMC scientists.

David Center, MD – Megan Bair-Merritt, MD, MSCE – In memoriam; Richard Saitz, MD MPH, FACP, DFASAM

  • Access the online version of the 2022 CTSI Impact here.